INTRODUCTION 4 8
Shellfish are among the most allergenic classes of seafood and the increase in demand for 4 9
were also performed. A positive SPT was defined with wheal diameter of at least 3 mm 1 1 6 greater than negative control accompanied by erythema 15 minutes after application of 1 1 7 extract or fresh forms of shrimp. patients with history of physician-diagnosed anaphylaxis treated with epinephrine, 1 3 0 antihistamines, steroids and/or albuterol were enrolled (Fig 1) . The shrimp were prepared 1 3 1 before the challenge by boiling in water for ≥ 10 minutes. The shrimp was given with 1 3 2 doubling increases every 15 minutes starting with 2 g until 32 g dose was reached (total 1 3 3 cumulative dose of 62 g). Vital signs (blood pressure, respiratory rate, and pulse rate) and 1 3 4 evidence of cutaneous, respiratory, gastrointestinal and cardiovascular signs and 1 3 5 symptoms were determined during the challenge. The challenge was discontinued if an 1 3 6 objective sign was elicited according to guidelines by the Work Group report on oral food 1 3 7 challenge testing. 19 Graded open OFC to shrimp was performed on 25 patients (Table 1) . The time reported 1 5 2 of patients having a reaction to shrimp before the OFC was between less than one to 45 1 5 3 years and 10 patients have never been exposed to shrimp. Eighteen patients passed the 1 5 4 challenge and were classified as shrimp tolerant (ST) patients. Seven patients developed 1 5 5 objective signs during the challenge at a median dose of 16 g (range: 2-32 g). Three 1 5 6 patients received epinephrine because of severity of symptoms. There were 5 patients in 1 5 7 the ST group who developed OAS symptoms that resolved without treatment and 1 5 8 completed the OFC without problems. None of the 7 patients who failed the OFC 1 5 9 developed biphasic allergic reactions. Five patients did not undergo OFC because of 1 6 0 history of physician-diagnosed anaphylaxis upon shrimp ingestion and together with the 1 6 1 7 patients who failed the OFC were classified as shrimp allergic (SA) patients. Patients 1 6 2 were further sub-categorized based on their HDM sensitivity, defined as sensitization to 1 6 3 major allergen cysteine protease only as this protein is not an allergen in shrimp (Der p 1 1 6 4 ≥ 0.35 kU A /L). SPT to HDM extract was not used as criteria to categorized HDM 1 6 5 sensitization as this extract contains HDM tropomyosin and may result in cross-1 6 6 sensitization with shrimp tropomyosin. There were 7 patients in the SA group with HDM 1 6 7 sensitization (SA+HDM), 11 patients in the ST group with HDM sensitization 1 6 8 (ST+HDM), 5 patients in the SA group without HDM sensitization (SA-HDM) and 7 in 1 6 9 the ST group without HDM sensitization (ST-HDM). The median sIgE to shrimp was elevated in SA (10.2 kU A /L) compared to ST (1.25 2 0 4 kU A /L) patients (p=0.042). Four patients from ST group (4/18, 22%) and one from SA 2 0 5 group (1/12, 8%) had negative sIgE to shrimp and other shrimp proteins. The median 2 0 6 sIgE to shrimp and HDM components, and cockroach was not different between groups 2 0 7 (Table 4 ). None of the NC had sensitization to shrimp. There was a trend toward a higher 2 0 8
proportion of SA patients with elevated sIgE than ST patients to rPen a 1 (SA: 83%, ST: 2 0 9 44%, p=0.058) and Der p 10 (SA: 83%, ST:39%, p=0.026) as shown in Table 4 In patients not sensitized to HDM, median sIgE to shrimp (p=0.012), Der p 10 (p=0.035) 2 1 7 and cockroach (p=0.004) were significantly higher in SA-HDM than ST-HDM patients, 2 1 8 while sIgE to rPen m 2, rPen m 3 and rPen m 4 were not different between the two 2 1 9 groups (Table 4 ). When sIgE was analyzed based on positive HDM sensitivity (Der p 1 ≥ 2 2 0 0.35 kU A /L), the median sIgE levels to shrimp, rPen a 1 and Der p 10 trended to be 2 2 1 higher in SA+HDM than ST+HDM but this was not significant, while median sIgE to 2 2 2 rPen m 2, rPen m3 and cockroach were higher in ST+HDM than SA+HDM patients, 2 2 3 again not statistically significant (rPen m 2 kU A /L: p=0.5442; rPen m 3 kU A /L: p=0.961; 2 2 4 cockroach kU A /L: p=0.961). 2 2 5 2 2 6 Shrimp sIgE and CRD as a diagnostic test 2 2 7
Since shrimp sIgE was higher in SA than ST patients, the cut-off value that would highly 2 2 8 predict clinical reactivity was determined. Currently, commercial sIgE testing have cut-2 2 9
off values set at 0.1 and 0.35 kU A /L. Cut-off levels for white shrimp sIgE were 2 3 0 determined, having 91.7% sensitivity and 16.7% specificity for 0.1 kU A /L, and 91.7% 
